Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing cancer risk without adequate data: a necessary evil

B L Weber

    Annals of Oncology : Official Journal of the European Society for Medical Oncology
    |November 18, 1998
    PubMed
    Summary

    French clinical guidelines are applauded despite limited supporting data. The development process is a model for other nations needing immediate patient guidance.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Distinct patterns of DNA copy number alterations associate with BRAF mutations in melanomas and melanoma-derived cell lines.

    Genes, chromosomes & cancer·2009
    Same author

    Clinical management of BRCA1 and BRCA2 mutation carriers.

    Oncogene·2006
    Same author

    Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse.

    The Journal of pathology·2006
    Same author

    Sex ratio skewing of offspring in families with hereditary susceptibility to breast cancer.

    Journal of medical genetics·2005
    Same author

    Array based CGH and FISH fail to confirm duplication of 8p22-p23.1 in association with Kabuki syndrome.

    Journal of medical genetics·2005
    Same author

    Germline CHEK2*1100delC mutations in breast cancer patients with multiple primary cancers.

    Journal of medical genetics·2004

    Area of Science:

    • Medical Guidelines Development
    • Clinical Practice Recommendations
    • Evidence-Based Medicine

    Background:

    • French clinical guidelines were developed amidst significant data scarcity.
    • Expert opinions varied due to the lack of empirical evidence.

    Discussion:

    • The immediate need for clinical guidance for patients and healthcare providers is highlighted.
    • The absence of data necessitates interim recommendations despite ongoing research.

    Key Insights:

    • The French guidelines offer crucial, timely direction for clinicians and patients.
    • The development methodology serves as a transferable model for international guideline creation.

    Outlook:

    • Further data acquisition is anticipated over several years.
    • The established guideline framework can be adapted and implemented globally.

    Related Experiment Videos